newsfilter
← Latest News
Business Wire·

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

- Gossamer to Present Preclinical Evidence of Synergistic Treatment Effect from Combination Seralutinib & Sotatercept in Models of PAH - Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company